tradingkey.logo

Harvard Bioscience Inc

HBIO
0.495USD
+0.023+4.92%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
22.08MMarktkapitalisierung
VerlustKGV TTM

Harvard Bioscience Inc

0.495
+0.023+4.92%

mehr Informationen über Harvard Bioscience Inc Unternehmen

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Harvard Bioscience Inc Informationen

BörsenkürzelHBIO
Name des UnternehmensHarvard Bioscience Inc
IPO-datumOct 21, 2013
CEODuke (John D)
Anzahl der mitarbeiter330
WertpapierartOrdinary Share
GeschäftsjahresendeOct 21
Addresse84 October Hill Rd
StadtHOLLISTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01746-1371
Telefon15088938999
Websitehttps://www.harvardbioscience.com/
BörsenkürzelHBIO
IPO-datumOct 21, 2013
CEODuke (John D)

Führungskräfte von Harvard Bioscience Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
311.13K
-110000.00%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
+110000.00%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
+87289.00%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
311.13K
-110000.00%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
+110000.00%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
+87289.00%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Instruments, equipment, software and accessories
18.58M
90.24%
Service, maintenance and warranty contracts
2.01M
9.76%
Nach RegionUSD
Name
Umsatz
Anteil
United States
9.25M
44.94%
Europe, Middle East and Africa
6.61M
32.10%
China
2.15M
10.42%
Rest of Asia
1.40M
6.78%
Americas - Other
1.19M
5.75%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Instruments, equipment, software and accessories
18.58M
90.24%
Service, maintenance and warranty contracts
2.01M
9.76%

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
AMH Equity, Ltd.
7.49%
Weber Capital Management, LLC
7.16%
Green (James W)
4.65%
Harvey Partners, LLC
4.58%
The Vanguard Group, Inc.
4.30%
Andere
71.82%
Aktionäre
Aktionäre
Anteil
AMH Equity, Ltd.
7.49%
Weber Capital Management, LLC
7.16%
Green (James W)
4.65%
Harvey Partners, LLC
4.58%
The Vanguard Group, Inc.
4.30%
Andere
71.82%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
17.62%
Investment Advisor
11.51%
Investment Advisor/Hedge Fund
9.16%
Individual Investor
8.73%
Venture Capital
7.16%
Pension Fund
2.03%
Research Firm
0.15%
Family Office
0.07%
Bank and Trust
0.01%
Andere
43.57%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
197
21.17M
47.34%
-11.22M
2025Q3
201
25.97M
58.27%
-8.70M
2025Q2
214
34.64M
78.35%
-7.01M
2025Q1
216
35.57M
80.46%
-4.66M
2024Q4
216
39.38M
90.28%
+2.67M
2024Q3
217
37.20M
85.38%
-773.14K
2024Q2
216
36.12M
83.22%
-2.57M
2024Q1
216
36.60M
84.34%
-2.39M
2023Q4
219
36.53M
85.65%
-2.57M
2023Q3
223
36.90M
86.54%
-1.23M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
AMH Equity, Ltd.
4.05M
9.09%
+538.83K
+15.36%
Aug 06, 2025
Weber Capital Management, LLC
3.20M
7.19%
+683.45K
+27.15%
Mar 31, 2025
Green (James W)
1.64M
3.68%
-392.52K
-19.34%
Aug 15, 2025
Harvey Partners, LLC
2.14M
4.81%
-46.40K
-2.12%
Jun 30, 2025
The Vanguard Group, Inc.
1.85M
4.16%
-284.86K
-13.32%
Jun 30, 2025
272 Capital LLC
1.56M
3.49%
+1.56M
--
Sep 30, 2024
Acadian Asset Management LLC
1.04M
2.33%
-37.84K
-3.51%
Jun 30, 2025
Duke (John D.)
1.00M
2.25%
+1.00M
--
Aug 08, 2025
Meros Investment Management, LP
919.95K
2.07%
+125.27K
+15.76%
Jun 30, 2025
Florida State Board of Administration
910.00K
2.04%
+130.66K
+16.77%
Jun 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Franklin US Small Cap Multifactor Index ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Lattice Hartford Multifactor Small Cap ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Proshares Ultra Russell 2000
0%
Mehr Anzeigen
Franklin US Small Cap Multifactor Index ETF
Anteil0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0%
Lattice Hartford Multifactor Small Cap ETF
Anteil0%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0%
ProShares Hedge Replication ETF
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
iShares Russell 2000 Growth ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%
DFA Dimensional US Sustainability Core 1 ETF
Anteil0%
Proshares Ultra Russell 2000
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI